REC 2615Alternative Names: REC 15/2615
Latest Information Update: 12 Oct 2015
At a glance
- Originator Recordati
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Female sexual dysfunction
Most Recent Events
- 10 Aug 2005 Phase-I clinical trials in Female sexual dysfunction in Italy (Topical)
- 08 Jan 2002 Preclinical development for Female sexual dysfunction in Italy (Topical)